the market?
ACHILLION PHARMACEUTICALS, INC...
NASDAQ: ACHN
7.58
-0.06
(-0.79%)
| Today's Open | $7.63 |
|---|---|
| Previous Close | $7.64 |
| Daily Range | $7.40 - $7.67 |
| 52-Week Range | $5.42 - $11.36 |
| Market Cap | $731.9M |
| P/E Ratio | -11.75 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 482,454 |
| Average Daily Volume | 957,265 |
| Current FY EPS | -$0.62 |
How do you think ACHN
will perform against the market?
Top ACHN Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
July 2, 2010
As hard as it might seem to justify green-thumbing a company that sounds like a sneeze, I'm going to give it a shot anyway. In 2006 Achillion (bless you) stock maxed out at 20 on the strength of a pa … More
zzlangerhans (< 20)
Submitted
December 14, 2010
Achillion survived a 50M dilutive financing in August to rise significantly after the initiation of the phase II trial of ACH-1625. These events mean that Achillion will end the year with a comfortabl … More
News & Commentary
Tough Day for This Hepatitis C Underdog
Is it too little too late for Achillion?1 Biotech Challenging the Hep-C Goliath
David is taking on Goliath in the gold mine hepatitis C industry.3 Horrendous Health-Care Stocks This Week
The week of April Fools' Day was no joking matter for these 3 stocks.Secondary Offerings: What You Need to Know
Why companies releasing more shares can hurt investors.3 Horrendous Health-Care Stocks This Week
Mr. Market rained on the parade this week for these 3 horrendous health-care stocks.Why Achillion Pharmaceuticals Shares Dove
Is this meaningful or just another movement?Sector
Healthcare
Industry
Drugs
ACHILLION PHARMACEUTICALS, INC. (ACHN) Description
A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases Website: http://www.achillion.com/
